The global coil-assisted flow diverters market is poised for significant expansion, projected to reach a value of USD 640.42 million by 2033, with a remarkable compound annual growth rate (CAGR) of 7.7% from 2023 to 2033. In 2022, the market is estimated to be valued at USD 283.2 million, marking a substantial growth trajectory over the next decade.
Key factors driving this growth include the escalating incidence of brain aneurysms and associated risk factors, alongside a burgeoning preference for minimally invasive treatment options. Public awareness campaigns about available treatments and governmental initiatives aimed at reducing intracranial aneurysm occurrences further bolster market expansion.
Get Sample Report Market: https://www.futuremarketinsights.com/reports/sample/rep-gb-12565
The approval of several devices by the FDA for treating cerebral aneurysms has notably propelled the adoption of coil-assisted flow diverters since 2021. This innovation is anticipated to eclipse the market dominance previously held by embolic coils, once considered the gold standard in cerebral aneurysm treatment.
“The coil-assisted flow diverters market is witnessing robust growth driven by technological advancements and increasing patient preference for minimally invasive therapies,” commented FMI. “As the market continues to evolve, we anticipate continued momentum in innovation and treatment efficacy.”
Key Takeaways from the Coil Assisted Flow Diverters (CAFD) market are as follows:
- The market for Coil Assisted Flow Diverters has been experiencing significant growth due to increasing cases of intracranial aneurysms and the need for effective treatment options. CAFD devices are being increasingly adopted as a minimally invasive treatment option, driving market demand.
- Coil Assisted Flow Diverters offer several advantages over traditional treatment methods for intracranial aneurysms. They provide better aneurysm occlusion rates, reduce the risk of recurrence, and have a lower risk of complications compared to other treatment options. These factors contribute to their rising popularity in the market.
- The market is witnessing continuous technological advancements in Coil Assisted Flow Diverters, leading to improved device designs and enhanced treatment outcomes. Manufacturers are focusing on developing devices with better navigability, increased flexibility, and improved flow diversion capabilities.
- The increasing prevalence of intracranial aneurysms globally is a significant driver for the Coil Assisted Flow Diverters market. Factors such as aging population, lifestyle changes, and improved diagnostic techniques contribute to the higher detection rate of aneurysms, thereby increasing the demand for effective treatment options like CAFD.
- Governments and healthcare organizations in several countries have recognized the clinical benefits of Coil Assisted Flow Diverters and have implemented favorable reimbursement policies. This has led to increased accessibility and affordability of CAFD devices, further boosting market growth.
Coil Assisted Flow Diverters Market: Drivers and Restraints:
Drivers:
- Growing prevalence of intracranial aneurysms: The incidence of intracranial aneurysms has been increasing globally, primarily due to factors such as aging populations, lifestyle changes, and improved diagnostic capabilities. This rising prevalence creates a significant demand for effective treatment options like CAFDs.
- Minimally invasive nature: Coil Assisted Flow Diverters offer a less invasive alternative to traditional surgical treatments for intracranial aneurysms. They can be placed using endovascular techniques, reducing the need for open surgery and associated risks, such as infection and longer recovery times. This minimally invasive nature attracts both patients and healthcare providers.
Restraints:
- High cost: The cost of CAFDs can be relatively high, including the cost of the device itself and the associated procedure. This can limit their adoption, especially in regions with limited healthcare budgets or where reimbursement policies may not adequately cover the expenses.
- Lack of awareness and expertise: CAFDs are relatively new in the market, and their adoption may be hindered by a lack of awareness and expertise among healthcare professionals. Training and education are crucial to ensure proper utilization of CAFDs and to increase their acceptance.
Coil Assisted Flow Diverters Market: Key Players
- Medtronic
- DePuy Synthes
- Stryker
- MicroPort
- OBEX Medical
- Abbott
- Cardiatis
- ADMEDES
- Penumbra Inc. and Balt.
Coil Assisted Flow Diverters Market: Segmentation
Applications:
- Wide-neck bifurcation aneurysms
- Bifurcation aneurysms
Distribution Channels:
- Hospitals
- Clinics
- Ambulatory Surgical Centres
Regional analysis includes
- North America (USA. Canada)
- Latin America (Mexico. Brazil)
- Western Europe (Germany Italy France, United Kingdom, Spain)
- Eastern Europe (Poland Russia)
- Asia-Pacific excluding Japan (China India ASEAN Australia & New Zealand)
- Japan
- Middle East and Africa (GCC Countries South Africa Northern Africa)
About Future Market Insights (FMI)
Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.
Contact Us:
Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-347-918-3531
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube